FDA Talks Up Continuous Manufacturing, Offers Assistance

It is time for drug makers to embrace continuous manufacturing methods, CDER Director Janet Woodcock and other FDA officials have been emphasizing in recent months. Now the agency is offering additional support to help manufacturers overcome regulatory barriers, real or perceived, and wean themselves from batch processes.